Lacutamab Uses, Dosage, Side Effects and more

Lacutamab is under investigation in clinical trial NCT02593045 (Study of IPH4102 in Patients With Relapsed/Refractory Cutaneous T-cell Lymphomas (CTCL)).

Attribute	Details
Trade Name	Lacutamab
Generic	Lacutamab
Lacutamab Other Names	Lacutamab
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph